Found 9 clinical trials
Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
Definitive chemoradiotherapy(CRT) has been regarded as a standard of care for patients with unresectable locally advanced esophageal cancer. Patients who are sensitive to CRT can achieve significantly down staging. Whether this part of patients could benefit from further surgical treatment remains unknown. Herein, a single center prospective randomized phase II …
- 1 views
- 16 Feb, 2022
- 1 location
Chemoradiotherapy in Unresectable Esophageal Cancer
This phase I/II clinical study is designed to evaluate the 1 year local tumor control rate of chemoradiotherapy using albumin-bound paclitaxel and cisplatin in unresectable esophageal squamous cell carcinomas based on Nutritional Risk Screening NRS2002.
- 0 views
- 27 Feb, 2022
- 1 location
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer (ARION)
oesophageal cancer. This is a randomized, French national, multicentre, comparative phase II trial
- 3 views
- 16 Feb, 2022
- 4 locations
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
This phase II clinical study is designed to evaluate the 1 year local tumor control rates after the targeted therapy of intensity-modulated radiation therapy synchronized chemotherapy with nimotuzumab combined with S-1 in local advanced esophageal squamous cell carcinomas based on Nutritional Risk Screening NRS2002.
- 1 views
- 28 Oct, 2021
- 1 location
Chemoradiotherapy for Advanced Esophageal Cancer (PaRCUS)
quality of life in patients with unresectable esophageal cancer.
- 0 views
- 22 Apr, 2022
- 1 location
Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer
convert some unresectable esophageal cancer into resectable esophageal cancer.PD-1 antibody has been shown to improve the pathological complete response rate in NSCLC, however, the data in neoadjuvant of
- 1 views
- 20 Feb, 2022
- 1 location
SOX-based CRT for Esophageal Cancer.
Patients with esophageal cancer that had locally advanced diseases or with unresectable diseases are being asked to participate in this phase I/II study. This phase I/II study is being conducted to determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and efficacy of IMRT combined with S-1 and Oxaliplatin (SOX) based …
- 11 views
- 10 Feb, 2022
- 1 location
Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer
Background: Esophageal cancer commonly occurs in middle-aged man. It is ranked to the 6th common cancer and 5th cancer-related death in Taiwanese male, and sometimes co-exist with oropharyngeal cancer, which impacts our national economics and productivity a lot. To improve the prognosis of esophageal cancer, we should contribute to early …
- 0 views
- 13 Jun, 2022
- 1 location
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
get surgical treatment because of the tumor metastasis at the time of diagnosis.Currently, chemoradiotherapy has become one of the standard treatment regimens for patients with unresectable esophageal
- 0 views
- 12 Feb, 2022
- 1 location